XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Significant Accounting Policies and Transactions (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of shares authorized for grant 1,500,000 1,500,000       1,500,000        
Number of options granted in period 297,974                  
Weighted average exercise price (in dollars per share) $ 8.39                  
Inventory write-down       $ 30,100,000            
Decrease in deferred tax asset valuation allowance     $ 123,200,000   $ 123,200,000   $ 123,200,000      
Deferred tax assets, net     0       0      
Percentage of tax benefit paid to equity owner           85.00%        
Obligations under tax receivable agreement $ 8,960,000 $ 8,960,000 9,562,000 $ 109,182,000   $ 8,960,000 9,562,000 $ 8,960,000 $ 8,960,000 $ 109,187,000
Liability reduction   $ 0 $ 99,620,000     $ 0 $ 99,620,000      
Restricted Stock Units (RSUs)                    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                    
Number of instruments granted in period (in shares)           481,510        
Weighted average grant date fair value (in dollars per share)           $ 8.39